METHANOL POISONING
METHANOL POISONING
批准号:
3269649
负责人:
THOMAS R TEPHLY
金额:
$13.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1977
资助国家:
美国
项目状态:
已结题
起止时间:
1977-12-01 至 1991-11-30
关键词:
acidosis alcohol dehydrogenase aldehyde dehydrogenases blood chemistry catalase central nervous system complementary DNA computer data analysis detoxification electrophysiology electroretinography endonuclease enzyme inhibitors enzyme mechanism evoked potentials eye fundus photography fluorescein angiography formaldehyde formates gel electrophoresis high performance liquid chromatography human tissue laboratory mouse laboratory rat liver cells liver metabolism methanol poisoning molecular cloning nucleic acid probes ophthalmoscopy optic neuritis pyrazoles radiotracer retina disorder species difference spectrometry visual stimulus
中文摘要
本项目的目的是揭示黄曲霉毒素的作用机制
人体内的甲醇中毒。据我们所知,只有人类和
猴子表现出特有的甲醇毒性,但毒性较低
动物,老鼠和大鼠,都不会。本实验室以前的工作
研究表明,猴子体内甲酸盐氧化的速度较慢
而肝脏中的四氢叶酸水平
对甲酸盐氧化的重要性在猴子中要低得多
在老鼠身上。
目前的建议是,首先,检查稳态
肝叶酸衍生物及其中间体的水平
叶酸生化途径。人体组织将由以下机构提供
器官移植捐赠者先和后由患者接受
上消化道手术。程序将包括快速
冷冻肝脏,然后进行高效液相分离和
用微生物生物测定法进行定量。低浓度的
人肝四氢叶酸和可能的低总肝
预计会有叶酸。这将支持这样的假设:
甲酸盐氧化在一定程度上取决于肝脏中
四氢叶酸。这些实验将与研究进行比较
对小鼠肝脏中叶酸水平的影响。小鼠代谢甲酸的速率
这是在老鼠身上观察到的三倍。我们假设肝脏
四氢叶酸在小鼠肝脏中的水平可能要高得多。
第二系列项目将研究酶的调节。
通过叶酸催化甲酸氧化成二氧化碳
系统;具体地说,以甲酰四氢叶酸为主导的调解
合成酶和甲酰四氢叶酸脱氢酶。人类
肝酶将在#年进行定量和定性研究。
胞质组分和均一状态。动能
实验和免疫定量实验将是
使用大鼠、小鼠和人的肝脏制剂进行实验。后来,
将进行分子生物学研究,以检查
这些蛋白质的合成可能存在基因调控。
还建议进行研究,以评估对
肝脏中的四氢叶酸水平。亚甲基的酶学研究
四氢叶酸还原酶、蛋氨酸合成酶和丝氨酸
羟甲基转移酶是人类肝脏的一种酶。
这些研究应该为监管提供洞察力
动物体内的甲酸和叶酸代谢,特别是在
人类。
英文摘要
The objective of this project is to reveal the mechanism of
methanol poisoning in humans. To our knowledge only humans and
monkeys display characteristic methanol toxicity whereas lower
animals, mice and rats, do not. Previous work in this laboratory
has shown that the rate of formate oxidation is slower in monkeys
than in rats and that hepatic tetrahydrofolate levels which are
important for formate oxidation are much lower in monkeys than
in rats.
The current proposal is designed, first, to examine steady-state
levels of hepatic folate derivatives and intermediates of the
folate biochemical pathway. Human tissues will be provided by
organ transplant donors first and later by patients undergoing
upper gastrointestinal surgery. Procedures will include rapid
freezing of livers followed by HPLC separations and
quantification by microbiological bioassay. Low concentrations of
human hepatic tetrahydrofolate and possibly low total hepatic
folate is expected. This would lend support to the hypothesis that
formate oxidation depends, in part, on hepatic levels of
tetrahydrofolate. These experiments will be compared to studies
on folate levels in mouse liver. Mice metabolize formate at rates
three times the rates observed in rats. We postulate that hepatic
tetrahydrofolate levels may be much higher in mouse liver.
A second series of projects will examine the enzymatic regulation
of formate oxidation to CO2 as catalyzed through the folate
system; specifically the mediation led by formyltetrahydrofolate
synthetase and formyltetrahydrofolate dehydrogenase. Human
liver enzymes will be studied quantitatively and qualitatively in
cytosolic fractions and in the homogeneous state. Kinetic
experiments and immunoquantitative experiments will be
performed using rat, mouse and human liver preparations. Later,
molecular biological studies will be performed to examine the
possible genetic regulation of synthesis of these proteins.
Studies are also proposed to evaluate the regulation of
tetrahydrofolate levels in liver. Enzymatic studies on methylene
tetrahydrofolate reductase, methionine synthetase and serine
hydroxymethyltransferase are described for human liver.
These studies should provide insights into the regulation of
formate and folate metabolism in animal species, especially in
humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DRUG AND STEROID GLUCURONYLTRANSFERASE ACTIVITIES
-
批准号:3273714
-
项目类别:
-
资助金额:$6.15万
-
财政年份:1985
-
负责人:THOMAS R TEPHLY
-
依托单位:
UDP GLUCURONOSYLTRANSFERASES IN PHARMACOLOGY
-
批准号:6385353
-
项目类别:
-
资助金额:$35.02万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
STUDIES ON UDP-GLUCURONOSYLTRANSFERASES
-
批准号:3273721
-
项目类别:
-
资助金额:$25.23万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
UDP-GLUCURONYLTRANSFERASES
-
批准号:3273715
-
项目类别:
-
资助金额:$2.65万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
UDP-GLUCURONOSYLTRANSFERASES IN PHARMACOLOGY
-
批准号:2174657
-
项目类别:
-
资助金额:$29.78万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
UDP GLUCURONOSYLTRANSFERASES IN PHARMACOLOGY
-
批准号:6179091
-
项目类别:
-
资助金额:$34.14万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
UDP-GLUCURONOSYLTRANSFERASES IN PHARMACOLOGY
-
批准号:2734405
-
项目类别:
-
资助金额:$33.63万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
UDP-GLUCURONOSYLTRANSFERASES IN PHARMACOLOGY
-
批准号:2174656
-
项目类别:
-
资助金额:$19.96万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
UDP GLUCURONOSYLTRANSFERASES IN PHARMACOLOGY
-
批准号:2749791
-
项目类别:
-
资助金额:$34.44万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
UDP-GLUCURONOSYLTRANSFERASES IN PHARMACOLOGY
-
批准号:2444486
-
项目类别:
-
资助金额:$32.52万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
UDP-GLUCURONOSYLTRANSFERASES
-
批准号:2174655
-
项目类别:
-
资助金额:$27.48万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
UDP-GLUCURONYLTRANSFERASES
-
批准号:3273711
-
项目类别:
-
资助金额:$16.35万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
UDP-GLUCURONOSYLTRANSFERASES
-
批准号:3273713
-
项目类别:
-
资助金额:$24.31万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
UDP-GLUCURONYLTRANSFERASES
-
批准号:3273720
-
项目类别:
-
资助金额:$22.8万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
UDP GLUCURONOSYLTRANSFERASES IN PHARMACOLOGY
-
批准号:6518981
-
项目类别:
-
资助金额:$35.93万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
UDP-GLUCURONYLTRANSFERASES
-
批准号:3273718
-
项目类别:
-
资助金额:$19.36万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
UDP-GLUCURONYLTRANSFERASES
-
批准号:3273719
-
项目类别:
-
资助金额:$20.15万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
UDP-GLUCURONOSYLTRANSFERASES
-
批准号:2174654
-
项目类别:
-
资助金额:$26.04万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
UDP-GLUCURONYLTRANSFERASES
-
批准号:3273717
-
项目类别:
-
资助金额:$18.72万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
DRUG AND STEROID GLUCURONYLTRANSFERASE ACTIVITIES
-
批准号:3273716
-
项目类别:
-
资助金额:$10.18万
-
财政年份:1979
-
负责人:THOMAS R TEPHLY
-
依托单位:
海外基金